Fluoroscopy And Mobile C Arms Market 2021
This Newly added report provided by Straits Research
Fluoroscopy And Mobile C Arms market, is a Skillful and Deep Analysis of the Present Situation and Challenges. Experts have studied the historical data and compared it with the current market situation. The Research Report covers all the necessary information required by new market entrants as well as the existing players to gain a deeper insight into the market.
Furthermore, the statistical surveying report focuses on the product specifications, cost, production capacity, marketing channel, list of the distributors, and a comprehensive analysis of the import and export of the product. Upstream raw materials, downstream demand analysis, as well as the list of consumers have been studied systematically, along with the supplier and cost of this industry. The product flow and distribution channel have also been presented in this research report.
January 25, 2021 Fourth-quarter highlights• Sales amounted to EUR 6.0 billion, with 7% comparable sales growth• Comparable order intake increased 7%• Income from continuing operations
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Philips delivers Q4 sales of EUR 6.0 billion, with 7% comp. sales growth; income from cont. .
Royal PhilipsJanuary 25, 2021 GMT January 25, 2021 • Comparable order intake increased 7% • Income from continuing operations increased to EUR 608 million, compared to EUR 550 million in Q4 2019 • Adjusted EBITA margin increased to 19.0% of sales, compared to 17.9% of sales in Q4 2019 • Income from operations improved to EUR 795 million, compared to EUR 730 million in Q4 2019 • EPS from continuing operations (diluted) amounted to EUR 0.66; Adjusted EPS increased to EUR 0.94, compared to EUR 0.83 in Q4 2019 • Operating cash flow improved to EUR 1,305 million, compared to EUR 1,271 million in Q4 2019
• Comparable order intake increased 7%
• Income from continuing operations increased to EUR 608 million, compared to EUR 550 million in Q4 2019
• Adjusted EBITA margin increased to 19.0% of sales, compared to 17.9% of sales in Q4 2019
• Income from operations improved to EUR 795 million, compared to EUR 730 million in Q4 2019
• EPS from continuing operations (diluted) amounted to EUR 0.66; Adjusted EPS increased to EUR 0.94, compared to EUR 0.83 in Q4 2019
• Operating cash flow improved to EUR 1,305 million, compared to EUR 1,271 million in Q4 2019
• Free cash flow improved to EUR 1,055 million, compared to EUR 959 million in Q4 2019
Full-year highlights
• Comparable order intake increased 9%
• Income from continuing operations increased to EUR 1,205 million, compared to EUR 1,192 million in 2019